Cancer Biostatistician / Professor / Data Scientist at the University of Michigan
Joined September 2019
- Tweets150
- Following112
- Followers111
- Likes758
If you are interested in external control arms in clinical trials and related topics, come join us Mon afternoon!
Special talk this afternoon- The inaugural Felix Feng Visiting Professorship. Dr. Paul Nguyen did phenomenal job highlighting the impact Felix had on so many of us.
Matthew Schipper retweeted
NEW: A novel tool predicts long-term risk of dying from #ProstateCancer, helping doctors interpret PSA results more accurately. Tested on over 200K men, it could help doctors tailor screening and treatment to individual risk and life expectancy. Read now: bit.ly/4pHyUwz @stensy @wandering_gu @UMichUrology #Cancer #CancerScreening
Matthew Schipper retweeted
Enhance your expertise in public health with our Summer Session in Epidemiology. Online from July 7-25, you'll gain skills in design and analysis of clinical trials from Dr. Matthew Schipper @StatMatt9 @umichsph
ALT Summer Session in Epidemiology Register Today Matthew Schipper instructor (pictured right) EPID 717: Design and Analysis of Clinical Trials 1 week course July 7-11 daily from 8:30am-12pm EDT Online only
Interesting timely article from @statnews
statnews.com/2025/06/06/us-u…
Matthew Schipper retweeted
Congratulations to Matt Schipper (@StatMatt9) for winning the @UMich Research Faculty Mentor Award. Matt has a tremendous record of supporting and training dozens of students, staff, trainees, and faculty, so this is very well-deserved! @UMichRadOnc @UMRogelCancer @MichRadOncRes
jamanetwork.com/journals/jam…
Nice editorial about 'skimming' the median - 1 number will not fully capture difference between 2 curves.
Matthew Schipper retweeted
A study from the @VAAnnArbor provides more data on the impact of lung cancer screening, this time evaluating the survival of a cohort of >2,000 screen-detected lung cancers. acsjournals.onlinelibrary.wi…
Matthew Schipper retweeted
It is with profound sadness that we mourn the passing of Felix Feng—an incredible father, husband, UCSF leader, pioneering scientist, entrepreneur, mentor, and cherished friend. Felix’s enduring kindness, brilliant mind, generous spirit, and transformative work in prostate cancer research have touched and saved countless lives. His legacy of compassion, innovation, and excellence will continue to inspire us all. My deepest condolences to Mary, Eric, & Emily during this heartbreaking time. May the One who brings Peace bring Peace to All.💔
Matthew Schipper retweeted
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study Out on Lancet Oncology
This retrospective cohort study aimed to evaluate the effectiveness and safety of immune checkpoint inhibitors (ICIs) in Black patients, who were underrepresented in clinical trials leading to ICIs’ approval. Using data from the U.S. Veterans Health Administration, the study included 26,398 patients, of whom 18.7% were Black and 81.3% were White. Results showed that Black patients had a longer time to treatment discontinuation, similar time to next treatment, and slightly improved overall survival compared to White patients. Additionally, Black patients experienced significantly fewer immune-related adverse events, including lower risks of colitis and thyroid issues. These findings suggest that Black patients may have a more favorable therapeutic ratio for ICI treatment, though further investigation is needed to assess the generalizability of these results.
@StatMatt9
@garthstrohbehn
@DariaBrinzevich
@KamyaSankar
buff.ly/4fBgtpa
Matthew Schipper retweeted
@UMichRadOnc is hiring! We have positions in both GU and Breast and are looking for enthusiastic candidates to apply and join an amazing team of clinicians, physicists, and biologists! #GoBlue. #theteam @ARRO_org @ASTRO_org @ACRORadOnc
Matthew Schipper retweeted
Fantastic work, @MLE_Alger, on presenting your first PhD paper @eClinicalMed! rb.gy/7xumij
Appreciate the great collaboration with our brilliant multidisciplinary co-authors @Anna_Minchom @lee_1881 @StatMatt9.
Keep up the amazing work! 👏 @ICR_CTSU
Delighted to present my review on the current landscape of Patient-Reported Outcomes in early phase dose-finding trials at @SCTorg’s Annual Meeting this week! #SCT2024
📌 doi.org/10.1016/j.eclinm.202…
Matthew Schipper retweeted
🌟 Introducing the Weiser Center for Prostate Cancer 🌟
A new era in #prostatecancer care begins at University of Michigan. Our mission: innovation, compassion, and #patientcenteredcare. Discover how:
🔗weiserprostatecancer.org
youtube.com/watch?v=pX33Hj5P… 📽️
Matthew Schipper retweeted
Excited to share our work showing the first validation of surrogate endpoints in HPV+ oropharyngeal cancer! We show that LRPFS, DMFS, and PFS correlate with 5yr OS. Important for trial design in this evolving dx space @MierzwaMichelle @StatMatt9 @NRGonc
sciencedirect.com/science/ar…
Matthew Schipper retweeted
Currently in the midst of a productive meeting with the @MROQC1 consortium, focused on enhancing the quality of radiation treatment across Michigan. #lungcancer @UMichRadOnc @UMRogelCancer – at Ann Arbor, MI
Matthew Schipper retweeted
Meet our instructors for the Clinical Epidemiology Cluster! EPID 716: Clinical Epidemiology & Evidenced-Based Research being taught by Dr. Caroline Thompson and EPID 717: Design and Analysis of Clinical Trials is being taught by @StatMatt9. Learn more at: myumi.ch/G1bbn
ALT Summer Session in Epidemiology Meet our instructors EPID 716: Clinical Epidemiology and Evidenced-Based Research Instructor: Dr. Caroline Thompson EPID 717: Design and Analysis of Clinical Trials Instructor: Dr. Matthew Schipper Apply for the 2023 Summer Session at SummerEpi.org
Matthew Schipper retweeted
Four decades of clinical trials: 14.2 million life-years gained, at $326 per year medicalxpress.com/news/2022-…
